Main competitors
Dividend Yield (Y) Dividend Yield (Y+1) P/E (Y) Price to Book (Y) EV / Sales (Y) EV / EBITDA (Y) EV / EBIT (Y) Capi.($)
-.--%-.--%15.6x3.04x2.75x8.5x8.35x 20.45B
0.62%0.7%16.45x1.91x3.57x9.64x10.55x 64.65B
0.56%0.58%28.14x4.2x5.7x16.49x21.05x 57.37B
-.--%-.--%33.12x6.68x11.21x21.14x25.02x 39.87B
4.12%4.25%-42.03x2.02x2.74x8.09x9.44x 33.6B
-.--%-.--%31.54x1.45x3.44x10.36x12.19x 28.84B
-.--%-.--%-5.49x3.23x7.31x-4.46x-4.23x 18.82B
-.--%0.06%49.25x4.9x5.24x37.64x34.29x 16.99B
-.--%-.--%25x3.5x5.17x13.94x19.4x 16.35B
-.--%-.--%-31.08x-5.39x14.66x-44.37x-46.14x 13.24B
-.--%-.--%-120.97x12305.08x12.02x-106.49x-120.82x 11.96B
0.15%0.16%60.51x25.14x38.04x51.45x52.83x 11.44B
-.--%-.--%16.12x - 3.46x12.68x15.2x 10.97B
-.--%-.--%38.61x - - - - 8.87B
2.82%3.26%11.95x1.04x1.82x7.34x9.77x 6.41B
-.--%-.--%-127.62x - - - - 6.27B
1.81%2.01%12.34x1.15x2.05x5.31x6.38x 5B
Average 0.59% 0.65% 0.67x 882.71x 7.94x 3.15x 3.55x 21.83B
Weighted average by Cap. 0.65% 0.69% 9.83x 429.97x 6.73x 8.09x 9.43x
Biopharmaceuticals